Tan Y, Sangfelt O, Spruck C: The Fbxw7/hCdc4 tumor suppressor in human cancer. Cancer Lett. 2008, 271: 1-12. 10.1016/j.canlet.2008.04.036.
Article
CAS
PubMed
Google Scholar
Welcker M, Clurman BE: FBW7 ubiquitin ligase: a tumour suppressor at the crossroads of cell division, growth and differentiation. Nat Rev Cancer. 2008, 8: 83-93. 10.1038/nrc2290.
Article
CAS
PubMed
Google Scholar
Orlicky S, Tang X, Willems A, Tyers M, Sicheri F: Structural basis for phosphodependent substrate selection and orientation by the SCFCdc4 ubiquitin ligase. Cell. 2003, 112: 243-256. 10.1016/S0092-8674(03)00034-5.
Article
CAS
PubMed
Google Scholar
Akhoondi S, Sun D, von der Lehr N, Apostolidou S, Klotz K, Maljukova A, Cepeda D, Fiegl H, Dafou D, Marth C, Mueller-Holzner E, Corcoran M, Dagnell M, Nejad SZ, Nayer BN, Zali MR, Hansson J, Egyhazi S, Petersson F, Sangfelt P, Nordgren H, Grander D, Reed SI, Widschwendter M, Sangfelt O, Spruck C: FBXW7/hCDC4 is a general tumor suppressor in human cancer. Cancer Res. 2007, 67: 9006-9012. 10.1158/0008-5472.CAN-07-1320.
Article
CAS
PubMed
Google Scholar
Hao B, Oehlmann S, Sowa ME, Harper JW, Pavletich NP: Structure of a Fbw7-Skp1-cyclin E complex: multisite-phosphorylated substrate recognition by SCF ubiquitin ligases. Mol Cell. 2007, 26: 131-143. 10.1016/j.molcel.2007.02.022.
Article
CAS
PubMed
Google Scholar
Knuutila S, Aalto Y, Autio K, Björkqvist AM, El-Rifai W, Hemmer S, Huhta T, Kettunen E, Kiuru-Kuhlefelt S, Larramendy ML, Lushnikova T, Monni O, Pere H, Tapper J, Tarkkanen M, Varis A, Wasenius VM, Wolf M, Zhu Y: DNA copy number losses in human neoplasms. Am J Pathol. 1999, 155: 683-694.
Article
CAS
PubMed
PubMed Central
Google Scholar
Rajagopalan H, Jallepalli PV, Rago C, Velculescu VE, Kinzler KW, Vogelstein B, Lengauer C: Inactivation of hCDC4 can cause chromosomal instability. Nature. 2004, 428: 77-81. 10.1038/nature02313.
Article
CAS
PubMed
Google Scholar
Matsuoka S, Oike Y, Onoyama I, Iwama A, Arai F, Takubo K, Mashimo Y, Oguro H, Nitta E, Ito K, Miyamoto K, Yoshiwara H, Hosokawa K, Nakamura Y, Gomei Y, Iwasaki H, Hayashi Y, Matsuzaki Y, Nakayama K, Ikeda Y, Hata A, Chiba S, Nakayama KI, Suda T: Fbxw7 acts as a critical fail-safe against premature loss of hematopoietic stem cells and development of T-ALL. Genes Dev. 2008, 22: 986-991. 10.1101/gad.1621808.
Article
CAS
PubMed
PubMed Central
Google Scholar
Mao JH, Perez-Losada J, Wu D, Delrosario R, Tsunematsu R, Nakayama KI, Brown K, Bryson S, Balmain A: Fbxw7/Cdc4 is a p53-dependent, haploinsufficient tumour suppressor gene. Nature. 2004, 432: 775-779. 10.1038/nature03155.
Article
CAS
PubMed
Google Scholar
Kimura T, Gotoh M, Nakamura Y, Arakawa H: hCDC4b, a regulator of cyclin E, as a direct transcriptional target of p53. Cancer Sci. 2003, 94: 431-436. 10.1111/j.1349-7006.2003.tb01460.x.
Article
CAS
PubMed
Google Scholar
Spruck CH, Strohmaier H, Sangfelt O, Müller HM, Hubalek M, Müller-Holzner E, Marth C, Widschwendter M, Reed SI: hCDC4 gene mutations in endometrial cancer. Cancer Res. 2002, 62: 4535-4539.
CAS
PubMed
Google Scholar
van Drogen F, Sangfelt O, Malyukova A, Matskova L, Yeh E, Means AR, Reed SI: Ubiquitylation of cyclin E requires the sequential function of SCF complexes containing distinct hCdc4 isoforms. Mol Cell. 2006, 23: 37-48. 10.1016/j.molcel.2006.05.020.
Article
CAS
PubMed
Google Scholar
Popov N, Herold S, Llamazares M, Schülein C, Eilers M: Fbw7 and Usp28 regulate myc protein stability in response to DNA damage. Cell Cycle. 2007, 6: 2327-2331. 10.4161/cc.6.19.4804.
Article
CAS
PubMed
Google Scholar
Moberg KH, Bell DW, Wahrer DC, Haber DA, Hariharan IK: Archipelago regulates Cyclin E levels in Drosophila and is mutated in human cancer cell lines. Nature. 2001, 413: 311-316. 10.1038/35095068.
Article
CAS
PubMed
Google Scholar
Malyukova A, Dohda T, von der Lehr N, Akhoondi S, Corcoran M, Heyman M, Spruck C, Grandér D, Lendahl U, Sangfelt O: The tumor suppressor gene hCDC4 is frequently mutated in human T-cell acute lymphoblastic leukemia with functional consequences for Notch signaling. Cancer Res. 2007, 67: 5611-5616. 10.1158/0008-5472.CAN-06-4381.
Article
CAS
PubMed
Google Scholar
Park MJ, Taki T, Oda M, Watanabe T, Yumura-Yagi K, Kobayashi R, Suzuki N, Hara J, Horibe K, Hayashi Y: FBXW7 and NOTCH1 mutations in childhood T cell acute lymphoblastic leukaemia and T cell non-Hodgkin lymphoma. Br J Haematol. 2009, 145: 198-206. 10.1111/j.1365-2141.2009.07607.x.
Article
CAS
PubMed
Google Scholar
Kwak EL, Moberg KH, Wahrer DC, Quinn JE, Gilmore PM, Graham CA, Hariharan IK, Harkin DP, Haber DA, Bell DW: Infrequent mutations of Archipelago (hAGO, hCDC4, Fbw7) in primary ovarian cancer. Gynecol Oncol. 2005, 98: 124-128. 10.1016/j.ygyno.2005.04.007.
Article
CAS
PubMed
Google Scholar
Bredel M, Bredel C, Juric D, Harsh GR, Vogel H, Recht LD, Sikic BI: Functional network analysis reveals extended gliomagenesis pathway maps and three novel MYC-interacting genes in human gliomas. Cancer Res. 2005, 65: 8679-8689. 10.1158/0008-5472.CAN-05-1204.
Article
CAS
PubMed
Google Scholar
Yokobori T, Mimori K, Iwatsuki M, Ishii H, Onoyama I, Fukagawa T, Kuwano H, Nakayama KI, Mori M: p53-Altered FBXW7 expression determines poor prognosis in gastric cancer cases. Cancer Res. 2009, 69: 3788-3794. 10.1158/0008-5472.CAN-08-2846.
Article
CAS
PubMed
Google Scholar
Iwatsuki M, Mimori K, Ishii H, Yokobori T, Takatsuno Y, Sato T, Toh H, Onoyama I, Nakayama KI, Baba H, Mori M: Loss of FBXW7, a cell cycle regulating gene, in colorectal cancer: clinical significance. Int J Cancer. 2010, 126: 1828-1837.
CAS
PubMed
Google Scholar
Jones PA, Baylin SB: The fundamental role of epigenetic events in cancer. Nat Rev Genet. 2002, 3: 415-428. 10.1038/nrg962.
Article
CAS
PubMed
Google Scholar
Herman JG, Baylin SB: Gene silencing in cancer in association with promoter hypermethylation. N Engl J Med. 2003, 349: 2042-2054. 10.1056/NEJMra023075.
Article
CAS
PubMed
Google Scholar
Maier S, Lesche R, Nimmrich I, Eckhardt F, Dahlstroem C, Plum A: DNA methylation markers- an opportunity to further individualize therapy in breast cancer?. Personalized Medicine. 2005, 2: 339-347. 10.2217/17410541.2.4.339.
Article
CAS
Google Scholar
Fiegl H, Jones A, Hauser-Kronberger C, Hutarew G, Reitsamer R, Jones RL, Dowsett M, Mueller-Holzner E, Windbichler G, Daxenbichler G, Goebel G, Ensinger C, Jacobs I, Widschwendter M: Methylated NEUROD1 promoter is a marker for chemosensitivity in breast cancer. Clin Cancer Res. 2008, 14: 3494-3502. 10.1158/1078-0432.CCR-07-4557.
Article
CAS
PubMed
Google Scholar
Verma M, Seminara D, Arena FJ, John C, Iwamoto K, Hartmuller V: Genetic and epigenetic biomarkers in cancer: improving diagnosis, risk assessment, and disease stratification. Mol Diagn Ther. 2006, 10: 1-15.
Article
CAS
PubMed
Google Scholar
Spruck C, Sun D, Fiegl H, Marth C, Mueller-Holzner E, Goebel G, Widschwendter M, Reed SI: Detection of low molecular weight derivatives of cyclin E1 is a function of cyclin E1 protein levels in breast cancer. Cancer Res. 2006, 66: 7355-7360. 10.1158/0008-5472.CAN-05-3240.
Article
CAS
PubMed
Google Scholar
Bergh J, Norberg T, Sjögren S, Lindgren A, Holmberg L: Complete sequencing of the p53 gene provides prognostic information in breast cancer patients, particularly in relation to adjuvant systemic therapy and radiotherapy. Nat Med. 1995, 1: 1029-1034. 10.1038/nm1095-1029.
Article
CAS
PubMed
Google Scholar
Miller LD, Smeds J, George J, Vega VB, Vergara L, Ploner A, Pawitan Y, Hall P, Klaar S, Liu ET, Bergh J: An expression signature for p53 status in human breast cancer predicts mutation status, transcriptional effects, and patient survival. Proc Natl Acad Sci. 2005, 102: 13550-13555. 10.1073/pnas.0506230102.
Article
CAS
PubMed
PubMed Central
Google Scholar
Sangfelt O, Cepeda D, Malyukova A, van Drogen F, Reed SI: Both SCF(Cdc4alpha) and SCF(Cdc4gamma) are required for cyclin E turnover in cell lines that do not overexpress cyclin E. Cell Cycle. 2008, 7: 1075-1082.
Article
CAS
PubMed
Google Scholar
Zilberman D, Henikoff S: Genome-wide analysis of DNA methylation patterns. Development. 2007, 134: 3959-3965. 10.1242/dev.001131.
Article
CAS
PubMed
Google Scholar
Agrelo R, Cheng WH, Setien F, Ropero S, Espada J, Fraga MF, Herranz M, Paz MF, Sanchez-Cespedes M, Artiga MJ, Guerrero D, Castells A, von Kobbe C, Bohr VA, Esteller M: Epigenetic inactivation of the premature aging Werner syndrome gene in human cancer. PNAS. 2006, 103: 8822-8827. 10.1073/pnas.0600645103.
Article
CAS
PubMed
PubMed Central
Google Scholar
Image J software. [http://rsb.info.nih.gov/ij]
DiNardo DN, Butcher DT, Robinson DP, Archer TK, Rodenhiser DI: Functional analysis of CpG methylation in the BRCA1 promoter region. Oncogene. 2001, 20: 5331-5340. 10.1038/sj.onc.1204697.
Article
CAS
PubMed
Google Scholar
Widschwendter M, Siegmund KD, Müller HM, Fiegl H, Marth C, Müller-Holzner E, Jones PA, Laird PW: Association of breast cancer DNA methylation profiles with hormone receptor status and response to tamoxifen. Cancer Res. 2004, 64: 3807-3813. 10.1158/0008-5472.CAN-03-3852.
Article
CAS
PubMed
Google Scholar
Strohmaier H, Spruck CH, Kaiser P, Won KA, Sangfelt O, Reed SI: Human F-box protein hCdc4 targets cyclin E for proteolysis and is mutated in a breast cancer cell line. Nature. 2001, 413: 316-322. 10.1038/35095076.
Article
CAS
PubMed
Google Scholar
Li J, Pauley AM, Myers RL, Shuang R, Brashler JR, Yan R, Buhl AE, Ruble C, Gurney ME: SEL-10 interacts with presenilin 1, facilitates its ubiquitination, and alters A-beta peptide production. J Neurochem. 2002, 82: 1540-1548. 10.1046/j.1471-4159.2002.01105.x.
Article
CAS
PubMed
Google Scholar
Yamasaki L, Pagano M: Cell cycle, proteolysis and cancer. Curr Opin Cell Biol. 2004, 16: 623-628. 10.1016/j.ceb.2004.08.005.
Article
CAS
PubMed
Google Scholar
Nakayama KI, Nakayama K: Ubiquitin ligases: cell-cycle control and cancer. Nat Rev Cancer. 2006, 6: 369-381. 10.1038/nrc1881.
Article
CAS
PubMed
Google Scholar
Sterian A, Kan T, Berki AT: Mutational and LOH analyses of the chromosome 4q region in esophageal adenocarcinoma. Oncology. 2006, 70: 168-172. 10.1159/000094444.
Article
CAS
PubMed
Google Scholar
Hicks J, Krasnitz A, Lakshmi B, Navin NE, Riggs M, Leibu E, Esposito D, Alexander J, Troge J, Grubor V, Yoon S, Wigler M, Ye K, Børresen-Dale AL, Naume B, Schlicting E, Norton L, Hägerström T, Skoog L, Auer G, Månér S, Lundin P, Zetterberg A: Novel patterns of genome rearrangement and their association with survival in breast cancer. Genome Res. 2006, 16: 1465-1479. 10.1101/gr.5460106.
Article
CAS
PubMed
PubMed Central
Google Scholar
Tovey S, Dunne B, Witton CJ, Forsyth A, Cooke TG, Bartlett JM: Can molecular markers predict when to implement treatment with aromatase inhibitors in invasive breast cancer?. Clin Cancer Res. 2005, 11: 4835-4842. 10.1158/1078-0432.CCR-05-0196.
Article
CAS
PubMed
Google Scholar
Vogel CL, Cobleigh MA, Tripathy D, Gutheil JC, Harris LN, Fehrenbacher L, Slamon DJ, Murphy M, Novotny WF, Burchmore M, Shak S, Stewart SJ, Press M: Efficacy and safety of trastuzumab as a single agent in first-line treatment of HER2-overexpressing metastatic breast cancer. J Clin Oncol. 2002, 20: 719-726. 10.1200/JCO.20.3.719.
Article
CAS
PubMed
Google Scholar
Sharma G, Mirza S, Yang YH, Parshad R, Hazrah P, Datta Gupta S, Ralhan R: Prognostic relevance of promoter hypermethylation of multiple genes in breast cancer patients. Cell Oncol. 2009, 31: 487-500.
CAS
PubMed
PubMed Central
Google Scholar
Chiang JW, Karlan BY, Cass L, Baldwin RL: BRCA1 promoter methylation predicts adverse ovarian cancer prognosis. Gynecol Oncol. 2006, 101: 403-410. 10.1016/j.ygyno.2005.10.034.
Article
CAS
PubMed
Google Scholar
Braggio E, Maiolino A, Gouveia ME, Magalhães R, Souto Filho JT, Garnica M, Nucci M, Renault IZ: Methylation status of nine tumor suppressor genes in multiple myeloma. Int J Hematol. 2010, 91: 87-96. 10.1007/s12185-009-0459-2.
Article
CAS
PubMed
Google Scholar
Morris MR, Ricketts C, Gentle D, Abdulrahman M, Clarke N, Brown M, Kishida T, Yao M, Latif F, Maher ER: Identification of candidate tumour suppressor genes frequently methylated in renal cell carcinoma. Oncogene. 2010, 29: 2104-2117. 10.1038/onc.2009.493.
Article
CAS
PubMed
PubMed Central
Google Scholar
Asnafi V, Buzyn A, Le Noir S, Baleydier F, Simon A, Beldjord K, Reman O, Witz F, Fagot T, Tavernier E, Turlure P, Leguay T, Huguet F, Vernant JP, Daniel F, Béné MC, Ifrah N, Thomas X, Dombret H, Macintyre E: NOTCH1/FBXW7 mutation identifies a large subgroup with favorable outcome in adult T-cell acute lymphoblastic leukemia (T-ALL): a Group for Research on Adult Acute Lymphoblastic Leukemia (GRAALL) study. Blood. 2009, 113: 3918-3924. 10.1182/blood-2008-10-184069.
Article
CAS
PubMed
Google Scholar
Finkin S, Aylon Y, Anzi S, Oren M, Shaulian E: Fbw7 regulates the activity of endoreduplication mediators and the p53 pathway to prevent drug-induced polyploidy. Oncogene. 2008, 27: 4411-4421. 10.1038/onc.2008.77.
Article
CAS
PubMed
Google Scholar
Gonzalez-Angulo AM, Hennessy BT, Mills GB: Future of Personalized Medicine in Oncology: A Systems Biology Approach. J Clin Oncol. 2010, 28: 2777-2783. 10.1200/JCO.2009.27.0777.
Article
CAS
PubMed
PubMed Central
Google Scholar
Jiang H, Reinhardt HC, Bartkova J, Tommiska J, Blomqvist C, Nevanlinna H, Bartek J, Yaffe MB, Hemann MT: The combined status of ATM and p53 link tumor development with therapeutic response. Genes Dev. 2009, 23: 1895-1909. 10.1101/gad.1815309.
Article
CAS
PubMed
PubMed Central
Google Scholar
Takao N, Kato H, Mori R, Morrison C, Sonada E, Sun X, Shimizu H, Yoshioka K, Takeda S, Yamamoto K: Disruption of ATM in p53-null cells causes multiple functional abnormalities in cellular response to ionizing radiation. Oncogene. 1999, 18: 7002-7009. 10.1038/sj.onc.1203172.
Article
CAS
PubMed
Google Scholar
Bryant HE, Schultz N, Thomas HD, Parker KM, Flower D, Lopez E, Kyle S, Meuth M, Curtin NJ, Helleday T: Specific killing of BRCA2-deficient tumours with inhibitors of poly(ADP-ribose) polymerase. Nature. 2005, 434: 913-917. 10.1038/nature03443.
Article
CAS
PubMed
Google Scholar
Mao JH, Kim IJ, Wu D, Climent J, Kang HC, DelRosario R, Balmain A: FBXW7 targets mTOR for degradation and cooperates with PTEN in tumor suppression. Science. 2008, 321: 1499-1502. 10.1126/science.1162981.
Article
CAS
PubMed
PubMed Central
Google Scholar